We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Merge Engages New York Investment Bank to Explore, Assess Strategic Options

By MedImaging International staff writers
Posted on 11 Sep 2012
Merge Healthcare, Inc. (Chicago, IL, USA), a leading provider of clinical systems, announced that its board of directors has retained Allen & Company, LLC (New York, NY, USA) investment bank, to help in investigating and evaluating a wide range of strategic alternatives, including (but not limited to), a sale of the company or a business combination.

Merge does not have a distinct timeline for the strategic review, and there is no guarantee that the review will result in any specific action or transaction. Company spokespersons stated that they are not commenting further regarding the evaluation of strategic alternatives, unless a definitive agreement for a specific transaction is entered into, the process is concluded, or it otherwise considers additional disclosure is suitable or required.

Merge’s enterprise and cloud-based solutions for image-intensive specialties provide access to any image, anywhere, any time. Moreover, Merge develops health stations, clinical trials software, and other health data and analytics systems that engage consumers in their personal health.

Related Links:

Merge
Allen & Company



Digital X-Ray Detector Panel
Acuity G4
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Breast Localization System
MAMMOREP LOOP
Biopsy Software
Affirm® Contrast

Channels

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.